Discovery, Characterization, & Advancement, of Novel Chemotypes of Potent & Selective Brain Penetrant & Peripherally Restricted NLRP3 Inhibitors
Time: 9:30 am
day: Day Two
Details:
- Exploring the drug discovery process: target identification and validation,
efficacy, pathway understanding and biomarkers - Discussing biomarker and patient status
- Reviewing latest data and future directions
